Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - teriparatide (rdna origin) - injection, solution - 750 mcg/3 ml - teriparatide (rdna origin) 750 mcg/3 ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - teriparatide -

Singapore - English - HSA (Health Sciences Authority)

accord healthcare private limited - teriparatide - injection, solution - teriparatide 20 mcg/80μl

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

asofarma s.a. - teriparatida (origen adn recombinante) - teriparatida (origen adn recombinante)....250.00mcg

United States - English - NLM (National Library of Medicine)

novocol pharmaceutical of canada, inc. - teriparatide (unii: 10t9csu89i) (teriparatide - unii:10t9csu89i) - teriparatide injection is indicated. - for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, teriparatide injection reduces the risk of vertebral and nonvertebral fractures. - to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy. - for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy. teriparatide injection is contraindicated in patients with hypersensitivity to teriparatide or to any of its excipients. hypersensitivity reactio